Recombinant Human SDH Protein，His

SDH, or succinate dehydrogenase, is a crucial enzyme within the mitochondrial respiratory chain, playing a dual role in both the tricarboxylic acid cycle and oxidative phosphorylation. Dysfunctional SDH is implicated in various metabolic disorders and certain types of cancer, notably paragangliomas and pheochromocytomas. The enzyme consists of four subunits—SDHA, SDHB, SDHC, and SDHD—that work in tandem to facilitate the conversion of succinate to fumarate while simultaneously reducing ubiquinone to ubiquinol. Due to its pivotal role in energy metabolism and reactive oxygen species production, understanding the structure and function of SDH is essential for elucidating its biochemical pathways and regulatory mechanisms. Research into SDH has gained momentum with advances in structural biology techniques, leading to detailed insights into its assembly, stability, and interactions with other metabolic pathways. Moreover, the characterization of pathogenic mutations in SDH subunits has opened new avenues for targeted therapies and biomarker discovery, emphasizing SDH as a significant focus in cancer research and metabolic disease. Comprehensive studies on SDH not only enhance our understanding of its fundamental biological functions but also potentially contribute to the development of novel therapeutic strategies for diseases associated with SDH dysfunction. As such, the ongoing investigation of SDH and its recombinant proteins serves as a cornerstone for both basic and applied research in biochemistry, molecular biology, and medical science.